Stock AUROPHARMA AUROBINDO PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

News Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Market Closed - NSE India S.E.
Other stock markets
 07:43:52 2024-06-12 am EDT 		5-day change 1st Jan Change
1,249 INR -0.64% Intraday chart for Aurobindo Pharma -1.38% +15.22%
Jun. 05 Hindalco-owned Novelis delays US IPO; shares slide RE
May. 27 Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hindalco-owned Novelis delays US IPO; shares slide
RE
Aurobindo Pharma : receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray
PU
Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit
MT
Transcript : Aurobindo Pharma Limited, Q4 2024 Earnings Call, May 27, 2024
Aurobindo Pharma : PR Q4 FY 2023 24
PU
Aurobindo Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Aurobindo Pharma : Q4FY24
PU
India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports
RE
Aurobindo Pharma Limited Receives an Order from the Deputy Commissioner, Punjagutta Division, Hyderabad
CI
Aurobindo Pharma Completes Sale of US Arm's Business Assets
MT
Maintainability Of Sister Ship Arrest On The Premise That Both Vessels Are Managed/operated By The Same Entity, While Each Ship Is Owned By Distinct One Ship Company – Bombay High Court
AQ
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President ­ R&D (Specialty Drug Delivery)
CI
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India
MT
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024
CI
Indian shares set to track Asian peers higher, eye on Fed meet
RE
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray
MT
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration
CI
Aurobindo Pharma Arm Restarts Distribution of Aseptic Products from Unit III
MT
APL Healthcare Limited Subsidiary of Aurobindo Pharma Limited Announces Unit Inspection Team of World Health Organization Conducts an Inspection at the Unit IV
CI
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUROPHARMA Stock
  4. News Aurobindo Pharma